Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Aapro

Showing results (31-40 of 237) with videos related to

Pageof 24
Sort By:
The Oncologist|September 19, 2009
Update on erythropoiesis-stimulating agents and clinical trials in oncologyMatti Aapro, Jerry L Spivak
The Oncologist|November 28, 2002
Incorporating oral capecitabine into the treatment of breast cancer. IntroductionAndrew D Seidman, Matti Aapro
Cancer Treatment Reviews|May 25, 2011
Importance of monitoring renal function in patients with cancerMatti Aapro, Vincent Launay-Vacher
The New England Journal of Medicine|April 7, 2016
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and VomitingRudolph M Navari, Matti Aapro
The Oncologist|November 6, 2010
Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastasesMatti Aapro, Fred Saad, Luis Costa
British Journal of Haematology|March 16, 2004
Is once-weekly epoetin beta 'highly effective' in treating anaemia in patients with lymphoproliferative malignancy?Carsten Bokemeyer, Tim Littlewood, Matti Aapro
Women'S Health (London, England)|October 7, 2009
Managing aromatase inhibitor-associated bone loss in breast cancerAllan Lipton, Michael Gnant, Matti Aapro
Future Oncology (London, England)|November 1, 2014
Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomitingVito Lorusso, Meinolf Karthaus, Matti Aapro
Therapeutic Advances in Medical Oncology|November 26, 2019
From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patientsMaurizio Muscaritoli, Jann Arends, Matti Aapro
Forum (Genoa, Italy)|March 14, 2003
Chemotherapy in the elderly with breast cancerLazzaro Repetto, Maria Pietropaolo, Matti Aapro
Pageof 24

Showing results (31-40 of 237) with videos related to

Sort By:
Pageof 24
The Oncologist|September 19, 2009
Update on erythropoiesis-stimulating agents and clinical trials in oncologyMatti Aapro, Jerry L Spivak
The Oncologist|November 28, 2002
Incorporating oral capecitabine into the treatment of breast cancer. IntroductionAndrew D Seidman, Matti Aapro
Cancer Treatment Reviews|May 25, 2011
Importance of monitoring renal function in patients with cancerMatti Aapro, Vincent Launay-Vacher
The New England Journal of Medicine|April 7, 2016
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and VomitingRudolph M Navari, Matti Aapro
The Oncologist|November 6, 2010
Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastasesMatti Aapro, Fred Saad, Luis Costa
British Journal of Haematology|March 16, 2004
Is once-weekly epoetin beta 'highly effective' in treating anaemia in patients with lymphoproliferative malignancy?Carsten Bokemeyer, Tim Littlewood, Matti Aapro
Women'S Health (London, England)|October 7, 2009
Managing aromatase inhibitor-associated bone loss in breast cancerAllan Lipton, Michael Gnant, Matti Aapro
Future Oncology (London, England)|November 1, 2014
Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomitingVito Lorusso, Meinolf Karthaus, Matti Aapro
Therapeutic Advances in Medical Oncology|November 26, 2019
From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patientsMaurizio Muscaritoli, Jann Arends, Matti Aapro
Forum (Genoa, Italy)|March 14, 2003
Chemotherapy in the elderly with breast cancerLazzaro Repetto, Maria Pietropaolo, Matti Aapro
Pageof 24